🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some professionals said the demand for the experimental drug could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer laws, risking fines, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The company stated it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at residence.

After minutes of joining one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts display dark colored parcels with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service said it regularly moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to potentially significant health risks”.